Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Australia moves closer to full disclosure of drug company payments to doctors.

Moynihan R.

BMJ. 2013 Jun 19;346:f3960. doi: 10.1136/bmj.f3960. No abstract available.

PMID:
23783360
2.

New year brings new transparency for drug company payments to doctors in UK.

Coombes R.

BMJ. 2015 Jan 2;350:g7748. doi: 10.1136/bmj.g7748. No abstract available.

PMID:
25555824
3.

Most Australians believe that drug company payments influence doctors' decisions.

Moynihan R.

BMJ. 2012 Feb 13;344:e1076. doi: 10.1136/bmj.e1076. No abstract available.

PMID:
22331321
4.

Drug company payments to doctors still hard to access despite disclosure laws.

Charatan F.

BMJ. 2007 Mar 31;334(7595):655. No abstract available.

5.

[Is it pertinent to investigate the relations between physicians and the drug industry].

Moliner J, Mozota J, Abad JM, Casaña L, Júdez D, Rabanaque MJ.

Rev Calid Asist. 2009 Apr;24(2):72-9. doi: 10.1016/S1134-282X(09)70656-6. Spanish.

PMID:
19426930
6.

Transparency urged over research payments.

Check E.

Nature. 2007 Aug 16;448(7155):738. No abstract available.

PMID:
17700667
7.

Consultation starts on how to reveal payments from industry to doctors.

Hawkes N.

BMJ. 2013 Jan 29;346:f615. doi: 10.1136/bmj.f615. No abstract available.

PMID:
23360723
8.

Sunlight as disinfectant--new rules on disclosure of industry payments to physicians.

Rosenthal MB, Mello MM.

N Engl J Med. 2013 May 30;368(22):2052-4. doi: 10.1056/NEJMp1305090. No abstract available.

9.

GMC says it can't force doctors to disclose payments from drug companies.

Torjesen I.

BMJ. 2016 Jul 7;354:i3806. doi: 10.1136/bmj.i3806. No abstract available.

PMID:
27390102
10.

Plan to force drug companies in France to reveal payments to doctors has been diluted, campaigners say.

Benkimoun P.

BMJ. 2012 Dec 12;345:e8405. doi: 10.1136/bmj.e8405. No abstract available.

PMID:
23236045
11.

Doctors and drug companies--scrutinizing influential relationships.

Campbell EG.

N Engl J Med. 2007 Nov 1;357(18):1796-7. No abstract available.

12.

Disclosure needs to include the extent of a relationship.

Fisher CM.

Med J Aust. 2006 Dec 4-18;185(11-12):673; author reply 674-5. No abstract available.

PMID:
17181524
13.

"Transparency reports" on industry payments to physicians and teaching hospitals.

Steinbrook R, Ross JS.

JAMA. 2012 Mar 14;307(10):1029-30. doi: 10.1001/jama.2012.211. Epub 2012 Feb 14. No abstract available.

PMID:
22336624
14.

Commercialism and medicine: an overview.

Kassirer JP.

Camb Q Healthc Ethics. 2007 Fall;16(4):377-86; discussion 439-42. Review. No abstract available.

PMID:
18018917
16.

Payments to doctors in Australia are to be scrutinised after marketing tactics are exposed.

Moynihan R.

BMJ. 2011 Oct 18;343:d6714. doi: 10.1136/bmj.d6714. No abstract available.

PMID:
22008810
17.

US intends to publish drug company payments to doctors from October despite calls for delay.

McCarthy M.

BMJ. 2014 Sep 16;349:g5693. doi: 10.1136/bmj.g5693. No abstract available.

PMID:
25227737
18.

Already feeling the heat: Docs rethinking payments as Sunshine Act looms.

Lee J.

Mod Healthc. 2013 Jul 1;43(26):12-3. No abstract available.

PMID:
23878901
19.

Distributions of industry payments to Massachusetts physicians.

Kesselheim AS, Robertson CT, Siri K, Batra P, Franklin JM.

N Engl J Med. 2013 May 30;368(22):2049-52. doi: 10.1056/NEJMp1302723. Epub 2013 May 1. No abstract available.

PMID:
23635021
20.

New York Times reveals payments to doctors by drug firms.

Spurgeon D.

BMJ. 2007 Mar 31;334(7595):655. No abstract available.

Supplemental Content

Support Center